Delivery Order SPE2DR25D3014-SPE2DR26FP2GT
Award Date 3/13/26
Potential Completion Date 4/3/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for pharmaceutical supply under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract supporting military healthcare programs globally through December 2026. Place of performance is Conshohocken, PA. The order calls for XDEMVY 0.25% DROP 10ML pharmaceutical product with an ultimate completion date of March 16, 2026. Pricing is firm fixed price with no...
- The Defense Logistics Agency issued a $3,553.80 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm...
- The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on February 20, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). The order is issued under the parent IDC held with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 13, 2026. Pricing is firm fixed price with no set-aside...
- The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for pharmaceutical supply under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 supporting global pharmaceutical and medical supply needs for military healthcare programs. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 2, 2026. No set-aside was used.
- The Defense Logistics Agency issued a $2,369.20 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for pharmaceutical supply XDEMVY 0.25% DROP 10ML. The order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that enables supply of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price, an...
- The Defense Logistics Agency issued a $1,184.60 delivery order to AmerisourceBergen Drug Corp on February 24, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 17, 2026, and is priced on a firm fixed-price basis. No set-aside was used. The delivery order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026,...
- The Defense Logistics Agency issued a $1,184.60 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, with an ultimate completion date of March 30, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. This firm fixed-price delivery order is for pharmaceutical products to support federal medical procurement. Place...
- <p>The Defense Logistics Agency issued a $3,553.80 delivery order to Amerisourcebergen Drug Corp on February 20, 2026, for pharmaceutical supply (4570902223 ! XDEMVY 0.25% DROP 10ML).</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of March 13, 2026.</p>
- <p>The Defense Logistics Agency issued a $3,553.80 delivery order to Amerisourcebergen Drug Corp on February 20, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). The order is placed against a DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999 through December 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 13, 2026. No set-aside applies.</p>
- <p>The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, under the DLA Troop Support Medical Indefinite Delivery Contract for pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 23, 2026, and carries firm fixed pricing. The delivery order covers XDEMVY 0.25% DROP 10ML pharmaceutical product.</p>
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP2GTDelivery Order
The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for pharmaceutical supply under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 3, 2026. The product delivered is identified in the award record as XDEMVY 0.25% DROP 10ML, a pharmaceutical product within DLA's medical supply portfolio. No set-aside was applied.
Generated 6/11/26, 10:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/12/26 |